Hikma Pharmaceuticals PLC : An opportune reversal
By Sandra Pinturault
Entry price | Target | Stop-loss | Potential |
---|---|---|---|
GBX 1,020 | GBX 0 | GBX 978 | -100% |
The company shows strong fundamentals. The revenues is expected to double in the next 5 years, which show a good long term vision of the group. In addition, the consensus revised upward EPS estimates for this year and that let see a great potential for the security on the stock market.
Technically, the uptrend in the medium and long term should protect the stock of a major downtrend. In the short term, a decline has led the share to the GBp 1000 support. Therefore, a technical rebound, already launched, will fix an objective near the GBp 1066 short-term resistance.
The GBp 1000 area represent an interesting purchase level to target GBp 1066, and by extension the GBp 1112. A stop loss will be fixed below the entry point to limit the risk.